UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases

Clinical gastroenterology and hepatology, 2020-05, Vol.18 (6), p.1324-1335.e2

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of IBD medications on COVID-19 outcomes: results from an international registry

Gut, 2021-04, Vol.70 (4), p.725

2021

Link zum Volltext

Verfügbarkeit prüfen

Squamous Cell Carcinoma of the Pouch

Inflammatory bowel diseases, 2022-07, Vol.28 (7), p.e99-e100

2022

Link zum Volltext

Verfügbarkeit prüfen

Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey

The lancet. Gastroenterology & hepatology, 2020-07, Vol.5 (7), p.631-632

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry

Gastroenterology (New York, N.Y. 1943), 2022-01, Vol.162 (1), p.316-319.e5

2022

Link zum Volltext

Verfügbarkeit prüfen

Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti–Tumor Necrosis Factor Therapy

Clinical gastroenterology and hepatology, 2010-12, Vol.8 (12), p.1048-1055

2010

Link zum Volltext

Verfügbarkeit prüfen

JAK inhibitor, a new player for treatment-refractory microscopic colitis

Intestinal research, 2023-07, Vol.21 (3), p.411-412

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial

Gastroenterology (New York, N.Y. 1943), 2022-11, Vol.163 (5), p.1294-1305.e3

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAID

Alimentary pharmacology & therapeutics, 2021-02, Vol.53 (3), p.400-409

2021

Link zum Volltext

Verfügbarkeit prüfen

Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study

Inflammatory bowel diseases, 2018-04, Vol.24 (5), p.1099-1105

2018

Link zum Volltext

Verfügbarkeit prüfen

Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer

Clinical epigenetics, 2017-05, Vol.9 (1), p.53-53, Article 53

2017

Link zum Volltext

Verfügbarkeit prüfen

Management of IBD Patients with Current Immunosuppressive Therapy and Concurrent Infections

Digestive diseases (Basel), 2015-01, Vol.33 (1), p.50-56

Rahier, Jean-François

2015

Link zum Volltext

Verfügbarkeit prüfen

Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient: A Clinical Quandary

Inflammatory bowel diseases, 2016-10, Vol.22 (10), p.2538-2547

2016

Link zum Volltext

Verfügbarkeit prüfen

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

Gastroenterology (New York, N.Y. 1943), 2020-08, Vol.159 (2), p.481-491.e3

2020

Link zum Volltext

Verfügbarkeit prüfen

Prevention and Management of Infectious Complications in IBD

Digestive diseases (Basel), 2012-01, Vol.30 (4), p.408-414

Rahier, Jean-François

2012

Link zum Volltext

Verfügbarkeit prüfen

First report of coexistence of MOG-antibody-positive disease and Crohn's disease

Multiple sclerosis and related disorders, 2019-02, Vol.28, p.1-3

2019

Link zum Volltext

Verfügbarkeit prüfen

Skipping Crohn's Disease: When Ileocolonoscopy Is Not Enough

Clinical gastroenterology and hepatology, 2012-11, Vol.10 (11), p.1260-1261

2012

Link zum Volltext

Verfügbarkeit prüfen

Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-up

Journal of pediatric gastroenterology and nutrition, 2016-08, Vol.63 (2), p.253-258

2016

Link zum Volltext

Verfügbarkeit prüfen

The European (ECCO) Consensus on infection in IBD: what does it change for the clinician?

Gut, 2009-10, Vol.58 (10), p.1313-1315

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(103)

Publikationsform

Artikel
(105)
Webseiten
(3)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Life Sciences & Biomedicine
(72)
Humans
(69)
Gastroenterology & Hepatology
(67)
Female
(40)
Male
(39)
Adult
(32)
Inflammatory Bowel Disease
(31)
Human Health Sciences
(29)
Sciences De La Santé Humaine
(29)
Gastroentérologie & Hépatologie
(28)
Middle Aged
(28)
Crohn's Disease
(19)
Inflammatory Bowel Diseases - Drug Therapy
(18)
Retrospective Studies
(18)
Young Adult
(15)
Aged
(14)
Risk Factors
(14)
Adolescent
(13)
Biological And Medical Sciences
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases

Effect of IBD medications on COVID-19 outcomes: results from an international registry

Squamous Cell Carcinoma of the Pouch

Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry

Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti–Tumor Necrosis Factor Therapy

JAK inhibitor, a new player for treatment-refractory microscopic colitis

Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial

Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAID

Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study

Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer

Management of IBD Patients with Current Immunosuppressive Therapy and Concurrent Infections

Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus

Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient: A Clinical Quandary

Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular study

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

Prevention and Management of Infectious Complications in IBD

First report of coexistence of MOG-antibody-positive disease and Crohn's disease

Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID study

H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy

Long-term Outcomes with Anti-TNF Therapy and Accelerated Step-up in the Prospective Pediatric Belgian Crohn's Disease Registry (BELCRO)

Skipping Crohn's Disease: When Ileocolonoscopy Is Not Enough

Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-up

The European (ECCO) Consensus on infection in IBD: what does it change for the clinician?

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE study

Suchergebnisse filtern